Nialamid

Izvor: Wikipedija
Prijeđi na navigaciju Prijeđi na pretragu
Nialamid
(IUPAC) ime
N-benzil-3-(N'-(piridin-4-karbonil)hidrazino)propanamid
Klinički podaci
AHFS/Drugs.com Internacionalno ime leka
Identifikatori
CAS broj 51-12-7
ATC kod N06AF02
PubChem[1][2] 4472
DrugBank DB04820
ChemSpider[3] 4317
UNII T2Q0RYM725 DaY
KEGG[4] D07337 DaY
Hemijski podaci
Formula C16H18N4O2 
Mol. masa 298,34 g/mol
SMILES eMolekuli & PubHem
Farmakoinformacioni podaci
Trudnoća ?
Pravni status Samo na recept (S4) (AU)
Način primene Oralno

Nialamid (Niamid) ireverzibilni i neselektivni je inhibitor monoaminske oksidaze (MAOI) iz hidrazinske hemijske klase, koji je korišten kao antidepresiv i anksiolitik.

Potencijalne primene[uredi | uredi kod]

Nialamid se ponekad koristi za tretman trigeminalne neuralgije, geleralizovanog anksioznog poremećaja i socijalne fobije. On je takođe izučavan za moguću primenu u tretmanu alkoholizma,[5] iregularne menstruacije,[6] angine,[7] cerebrovaskularnih poremećaja,[8] i za prevenciju streptomicinom indukovane gluvoće.[9]

Reference[uredi | uredi kod]

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H. 
  5. Bobrov AE, Shurygin AN, Krasil'nikov SB (1991). „[Effectiveness of combined use of monoamine oxidase inhibitors and psychotherapy in the treatment of chronic alcoholism]”. Zhurnal Nevropatologii i Psikhiatrii Imeni SS Korsakova. 91 (2): 79–83. PMID 1647635. 
  6. Gautray JP, Jolivet A (1976). „[Neuroendocrine investigation and therapy of the menstrual ćcle disorders (author's transl)(proceedings)]”. Annales d'endocrinologie 37 (4): 293–4. PMID 1022189. 
  7. Barats SS, Oranskii IE, Kartashova DI, Gorovater EN (1976). „[Comparative clinico-physiological stuđ of the effect of several MAO inhibitors in stenocardia]”. Kardiologiia 16 (3): 138–40. PMID 1021625. 
  8. Mirzoian RS (1975). „[Prevention of cerebrovascular disorders with adrenergic substances]”. Biulleten' Eksperimental'noi Biologii i Meditsinj 80 (11): 50–3. PMID 1218262. 
  9. Semczuk B, Klonowski S, Golabek W (1974). „The protective effect of niamid on hearing in patients treated with large doses of streptomycin”. Annales Universitatis Mariae Curie-Sklodowska Sectio D: Medicina 29 (1): 193–7. PMID 4467804. 

Vidi još[uredi | uredi kod]

Spoljašnje veze[uredi | uredi kod]